Olli Kalliioniemi

Olli Kalliioniemi

Company: Karolinska Institute

Job title: Professor & Director Science for Life Laboratory


Olli Kallioniemi, M.D., Ph.D. Director of Science for Life Laboratory (www.SciLifeLab.se), a national infrastructure for life sciences in Sweden and professor in Molecular Precision Medicine at the Karolinska Institutet (since 2016).  After a postdoc at UC San Francisco in 1990-1992 he was nominated as faculty at the National Human Genome Research Institute (1995-2002). He was then the founding director of FIMM – the Institute for Molecular Medicine Finland (www.fimm.fi) at the University of Helsinki, as part of the Nordic EMBL partnership in Molecular Medicine (2007-2015). Prof. Kallioniemi’s research group is currently active in individualized systems medicine of cancer, with a focus on improving the diagnostics and therapy of leukemia and ovarian cancer. Olli Kallioniemi is an author of 379 PubMed publications (with 42,996 citations, H-index of 102) and an inventor of several patents on diagnostic and genomic technologies, such as FISH, CGH, tissue microarrays, cell microarrays and bioinformatic methods.  He is a recipient of multiple awards, such as the Anders Jahre Prize, NIH Director’s lecture, Harold G. Pritzker Memorial Lecture (Toronto), AACR team science award and the IFCC-Abbot Award for Molecular Diagnostics and national medical awards in Finland and Sweden. Olli Kallioniemi is a member of European Molecular Biology Organization (EMBO), European Academy of Cancer Sciences as well as the Nobel Assembly at the Karolinska Institutet.

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.